SI-BONE (SIBN) Expected to Announce Quarterly Earnings on Monday

SI-BONE (NASDAQ:SIBN - Get Free Report) is expected to post its quarterly earnings results after the market closes on Monday, February 24th. Analysts expect SI-BONE to post earnings of ($0.16) per share and revenue of $48.87 million for the quarter. Parties interested in participating in the company's conference call can do so using this link.

SI-BONE Stock Down 0.6 %

SIBN stock traded down $0.11 during mid-day trading on Thursday, hitting $18.00. 314,520 shares of the company were exchanged, compared to its average volume of 324,770. The company has a market capitalization of $754.88 million, a PE ratio of -19.57 and a beta of 1.17. The firm has a fifty day simple moving average of $15.48 and a 200 day simple moving average of $14.61. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. SI-BONE has a twelve month low of $11.70 and a twelve month high of $20.94.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Needham & Company LLC restated a "buy" rating and set a $19.00 price objective on shares of SI-BONE in a research note on Monday, January 13th. Truist Financial upped their price target on SI-BONE from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, November 13th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, SI-BONE currently has a consensus rating of "Buy" and an average target price of $23.00.

Insider Buying and Selling

In related news, insider Anthony J. Recupero sold 3,670 shares of SI-BONE stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.90, for a total value of $51,013.00. Following the sale, the insider now directly owns 222,814 shares in the company, valued at $3,097,114.60. This trade represents a 1.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Anshul Maheshwari sold 5,304 shares of the business's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total transaction of $73,778.64. Following the transaction, the chief financial officer now directly owns 189,319 shares of the company's stock, valued at $2,633,427.29. The trade was a 2.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,311 shares of company stock valued at $130,356. Insiders own 3.90% of the company's stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.